Covered recipient · General Payments record
MARCO A ALBORNOZ
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$3,950.76
- Reported across 214 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $470.48 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $329.71 | 13 |
| Janssen Biotech, Inc. | $91.48 | 1 |
| GENZYME CORPORATION | $33.57 | 2 |
| ANI Pharmaceuticals, Inc. | $15.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.90 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512928 | CMS |
| Amgen Inc. | $18.47 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512930 | CMS |
| Amgen Inc. | $21.03 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512932 | CMS |
| Amgen Inc. | $22.25 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512918 | CMS |
| Amgen Inc. | $21.02 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512934 | CMS |
| Amgen Inc. | $17.18 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512936 | CMS |
| Amgen Inc. | $17.68 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512920 | CMS |
| Amgen Inc. | $16.16 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512938 | CMS |
| Amgen Inc. | $11.16 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512922 | CMS |
| Amgen Inc. | $17.44 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512940 | CMS |
| Amgen Inc. | $19.30 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512924 | CMS |
| Amgen Inc. | $12.91 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111512926 | CMS |
| Amgen Inc. | $115.21 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117491390 | CMS |
| ANI Pharmaceuticals, Inc. | $15.72 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091153082 | CMS |
| GENZYME CORPORATION | $18.02 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139594148 | CMS |
| GENZYME CORPORATION | $15.55 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139594180 | CMS |
| Janssen Biotech, Inc. | $91.48 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078578804 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.